Resource

Optimizing Technology and Automation for Digital Health Products

Accurate and culturally appropriate translation of clinical outcome assessments (COAs), including patient-reported outcome measures, is essential to ensuring reliable data in multinational trials. Foundations of Clinical Outcome Assessment Localization will provide a practical overview of why linguistic validation goes beyond standard translation and how it safeguards both data integrity and patient understanding. The session will cover current regulatory guidance, the steps...

Resource

Global by Design: Localizing UI/UX for Health Mobile Apps

In today’s global digital health landscape, localization goes far beyond translation. In health mobile applications, it means tailoring the user experience to cultural, linguistic, and even regulatory nuances across different regions. This discussion explores how localization in UI/UX design can significantly improve accessibility, trust, and engagement with health apps around the world....

Resource

Optimizing COA/eCOA Workflows with Technology for Better Quality & Timelines

Efficient workflows are critical to keeping global COA/eCOA studies on schedule while ensuring the quality of localized content. This live webinar will explore how technology stacks and automation can streamline clinical localization from start to finish, through integrating translation management systems with EDC platforms, eCOA platforms, and eCOA libraries, as well as how to leverage automation for KPI tracking and workflow efficiency. The webinar will also clarify when to...

Resource

Integrating AI to Scale & Accelerate Workflows and Improve Pharma Product Launches

Bringing a new medical product to market has always been a challenge, though advances in recent tools have promised a new age of streamlined processes and accelerated time to launch. However, most pharma commercial AI pilots never make it past proof of concept due to siloed workflows, data fragmentation, regulatory and IT bottlenecks, and quality risks. Join us for a webinar with TransPerfect’s commercial and AI experts, who will walk through practical workflows and...

Resource

Process AI in Medical Device: What Works and What’s Next

The webinar will also explore the use of Process AI across life sciences operations. Instead of treating each process, such as post-market surveillance, complaint handling, systematic literature review and regulatory content authoring, like separate AI projects, this session will show how the same core tasks (like classification, extraction, summarization and generation) can be mixed and matched. With these building blocks in place, attendees will be able to create reviewer...

Resource

Web Localization Playbook for Clinical Trials

Clinical trial websites are recruitment engines. Every update must stay accurate, compliant, and consistent across languages. Yet many teams still manage localization with file handoffs, dev tickets, and manual copy/paste that can’t scale. This playbook covers… ...

Resource

How Medical Communications Teams Can Scale Reviews Without Sacrificing Speed

Medical communications teams are under mounting pressure to review more content than ever before without adding headcount or increasing risk. This white paper outlines five pillars for rethinking MLR workflows, from modular content and tiered reviews to automation and governance. Get a realistic roadmap to alleviate team burnout, scale reviews, remove bottlenecks, and stay compliant....

Resource

LifeSci Talks COA Series | Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a behind-the-scenes look at the reality of patient-centered instrument development. They discuss diaries and quality of life tools, rare disease challenges, and proxy reporting, as well as the tradeoffs that can often occur in balancing regulatory rigor, patient burden, and...

Resource

Prepared, Not Overbuilt: How Smart Life Sciences Organizations Set Themselves Up for Commercialization, Global Partnerships, Licensing, and IPOs

The reality of most early-stage start up teams is that they are doing ten jobs at once. But waiting too long to organize documentation, content, and operations can slow everything down when it matters most. This guide shares how lean life sciences organizations prepare for commercialization and partnerships without overengineering their workflows....

Resource

C3 Summit 2025 - San Francisco

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to commercialization. The event offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. Please fill out the form to access the session...

Resource

The Clinical Trial Website Localization Buyer’s Guide

Every week a recruitment page isn't live in the right language is a week of enrollment you're not getting back. Selecting a website localization solution is more than a technology decision — it's a question of how fast your team can move, how much IT burden you're willing to carry, and whether your workflow can survive a protocol amendment. This guide breaks down…...

Resource

LifeSci Talks COA Series | More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner at Sprout Health Solutions, to discuss how pharma companies of all sizes can build a comprehensive, patient-centric evidence strategy that spans the entire drug development pathway. Together, they examine the growing role of COA and in-study interviews in regulatory decision-making, the practical barriers to earlier...

Resource

C3 Summit 2025 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to commercialization. The event offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. Please fill out the form to access the session...

Resource

LifeSci Talks COA Series | Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started sacrificing “good for perfect.” Together, they explore the role of regulatory guidance and clinical development timelines, specifically the role of measurement science in already tight development timelines,...

Resource

Buyer's Guide: Translation Management Integration with Veeva Vault RIM

Translation bottlenecks, fragmented audit trails, and uncontrolled AI output aren't edge cases in regulatory operations; they're the predictable result of a poorly integrated workflow. This buyer's guide is built for regulatory leaders who need more than a file-moving connector between their TMS and Veeva Vault RIM. Inside, you'll find a detailed evaluation framework, a vendor due diligence checklist, and a breakdown of the compliance, AI governance, and...

Resource

Top 10 Prompts to Ask ChatGPT for Optimizing Clinical Trial Recruitment Strategies

Patient recruitment and engagement are critical to the success of clinical trials. Yet despite the tremendous progress made in drug development, recruitment and retention remain major challenges. Over the last 25 years, the industry has attempted to crack the code; however, 86% of trials still don’t meet original enrollment goals. A bit curious yet somewhat cynical, I turned to ChatGPT to see if it could shed some light on this age-old problem. If you’re like me and...

Resource

EU CTR: An Introduction to European Clinical Trial Transparency

Are you looking to stay ahead of the curve in the ever-evolving landscape of European clinical trials? We are thrilled to announce the availability of our newest on-demand webinar, in which we dive deep into the recent changes to the European Clinical Trial Regulation (EU CTR) and how they impact the world of clinical research. Access this webinar and gain invaluable insights on: 1) Overview of the new EU CTR: Understand the latest regulations governing clinical...

Resource

Beyond Borders: Navigating the Complexities of Omnichannel Content Strategy for Global and Local Markets

Hosted by Christine Buggle, Senior Director at TransPerfect Life Sciences, in discussion with Ewelina Knigawka, Executive Director of Content and Partnership Excellence at Novartis, and Scott Dille, Digital Content Lead at Novo Nordisk, this session outlined key considerations when implementing a successful global to local omnichannel strategy. Additional topics in the conversation included: - Establishing a global governance structure for omnichannel: Ensuring a...

Resource

Transitioning Clinical Trials Under the EU CTR

The transition from Clinical Trial Directive to Clinical Trial Regulation in Europe adds new requirements and complexities to the clinical development landscape. The required transition of all trials concluding January 1st, 2025 brings about several considerations to ensure compliance. In this webinar featuring TransPerfect Life Sciences Executive Director Pierre-Frederic Omnes, we explore topics surrounding trial transitions, and answer common questions including: • Which...